Green Planet Bio Engineering Co. Ltd. SEC filings GPLB
Green Planet Bio Engineering Co. Ltd. has 154 filings in SEC EDGAR's recent list, going back to May 2, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on May 15, 2025 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Late filing notice | Apr 1, 2014 | Dec 31, 2013 |
| NT 10-Q | Late filing notice | Aug 15, 2013 | Jun 30, 2013 |
| NT 10-Q | Notice of late filing | May 16, 2013 | Mar 31, 2013 |
| NT 10-K | Late filing notice | Apr 2, 2013 | Dec 31, 2012 |
| NT 10-Q | Late filing notification | Aug 15, 2012 | Jun 30, 2012 |
| UPLOAD | Letter from the SEC | May 9, 2012 | — |
| CORRESP | Letter to the SEC | May 8, 2012 | — |
| UPLOAD | Letter from the SEC | May 4, 2012 | — |
| CORRESP | Letter to the SEC | May 2, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2012 | — |
| NT 10-K | Late filing notice | Apr 2, 2012 | Dec 31, 2011 |
| SC 14F1 | Information statement | Mar 23, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2011 | — |
| CORRESP | Letter to the SEC | Dec 2, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2011 | — |
| NT 10-Q | Extension | Nov 15, 2011 | Sep 30, 2011 |
| UPLOAD | Letter from the SEC | Jun 6, 2011 | — |
| CORRESP | Letter to the SEC | May 27, 2011 | — |
| PRER14C | Amendment no. 3 | May 27, 2011 | — |
| UPLOAD | Letter from the SEC | May 2, 2011 | — |
| CORRESP | Letter to the SEC | Apr 22, 2011 | — |
| PRER14C | Revised preliminary information statement | Apr 22, 2011 | — |
| NT 10-K | Notification of late filing | Apr 1, 2011 | Dec 31, 2010 |
| UPLOAD | Letter from the SEC | Mar 4, 2011 | — |
| PRER14C | Revised preliminary information statement | Feb 25, 2011 | — |
| CORRESP | Letter to the SEC | Feb 24, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2011 | — |
| NT 10-Q | Form 12b-25 | Aug 16, 2010 | Jun 30, 2010 |
| UPLOAD | Letter from the SEC | Feb 12, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2010 | — |
| NT 10-K | Form 12b-25 | Mar 31, 2009 | Dec 31, 2008 |
| UPLOAD | Letter from the SEC | Jan 12, 2009 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2009 | — |
| SC 14F1 | Filing | Nov 12, 2008 | — |
| SC 14F1 | Filing | Oct 9, 2008 | — |
| 10KSB | Mondo acq ii form 10-ksb | Apr 15, 2008 | Dec 31, 2007 |
| NT 10-K | Mondo acquisition ii, inc | Apr 1, 2008 | Dec 31, 2007 |
| 10QSB | Mondo ii form 10-qsb | Nov 14, 2007 | Sep 30, 2007 |
| 10QSB | Mondo acquisition ii, inc. form 10-qsb | Aug 20, 2007 | Jun 30, 2007 |
| NT 10-Q | Mondo acquisition ii, inc. | Aug 15, 2007 | Jun 30, 2007 |
| 10SB12G | Form 10-sb for mondo acquisition ii | May 2, 2007 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GPLB (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Aventura, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1392449
- Former names
- Mondo Acquisition II, Inc. (until Oct 9, 2008)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.